E-therapeutics, the systems biology drug discovery company, is launching a consultancy service to help pharmaceutical and biotechnology groups make their research more cost-effective.

E-therapeutics has worked on projects with GlaxoSmithKline, Mylan Laboratories, Cambridge Laboratories and Chakra Biotech. Its contract research consultancy service will use its patented in-silico technology to analyse drug compounds for indication, efficacy and toxicity.